Pfizer Inc. (PFE) - Long-Term Debt to Capital

Corporate emblem and logo of pfizer.com (PFE)

Pfizer Inc. (PFE) relies on skilled management that adeptly integrates acquired assets and develops a transparent pipeline, as reflected in this chart where the asset value reaches 0.72. Production is based on sterile automated complexes and AI-driven molecular modeling. Stability of supply is guaranteed by a streamlined global distribution network utilizing advanced packaging systems and flexible transportation routes.

PFE - Pfizer Corporation Long-Term Debt to Equity over the range 07/04/2022 - 10/28/2026
Signature product of pfizer.com

This indicator measures the proportion of long-term liabilities relative to equity, determining the degree of financial leverage and the company's dependence on borrowed funds for long-term planning. By analyzing the long-term debt-to-equity ratio, an investor assesses the resilience of Pfizer Inc. (PFE) to market shocks, which is critical during large-scale investments in production robotization and the implementation of AI in clinical trials.